ValveCure is a development stage company in the structural heart space, focusing on valvular insufficiency.
Our proprietary method of tightening the annulus of the valve has been
demonstrated in our successful Pre-Clinical studies to eliminate mitral regurgitation,
and acutely and durably reduced the A/P dimension by ~ 20%, considered
clinically meaningful, through 180 days in the Chronic study.
Our proprietary delivery platform uses a simple and elegant application of
RF energy that is not an implant. Allows an in vivo view of the area of the
annulus to be treated. Please see the "Our Products" page for the animation.